Documentos de López-López M. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Publisher: "Pharmacogenomics"

Subtipo de publicación

Conference Object(1)

Área temáticas

Farmacología y terapéutica(4)

Enfermedades(2)

Medicina y salud(2)

Ginecología, obstetricia, pediatría, geriatría(1)

Área de conocimiento

Farmacología(2)

Salud pública(1)

Año de Publicación

Origen

Palabras Claves

pharmacogenetics(4)

Mexican-Mestizo(2)

CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas

Abstract: Aim: In previous CYP2D6 genotyping studies in Mexican-Amerindians a very low frequency of poor metab

Palabras claves:

CYP2D6, Lacandones, Mexican-Mestizo, pharmacogenetics

Adrián LLerena, Alonso E., Dorado P., López-López M., Ochoa-Morales A., Ortega A., Penãs-Lledó E.M., Vázquez T.C., Yescas-Gómez P.

Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in Mexican-Mestizo healthy volunteers

Abstract: Aim: To determine allele and genotype frequencies of genes influencing anti-epileptic drug therapy i

Palabras claves:

ABCC2, anti-epileptics, CYP3A5, EPHX1, GABRA1, HNF4A, Mexican-Mestizo, NR1I2, pharmacogenetics, RALBP1, SCN1A, SCN2A, UGT1A1, UGT2B7

Adrián LLerena, Dorado P., Fricke-Galindo I., Jung-Cook H., López-López M., Monroy-Jaramillo N., Ortega-Vázquez A., Penãs-Lledó E.M.

Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America

Conference Object

Abstract: Congress of Pharmacogenetics and Personalized Medicine. Ethnicity, clinical implementation and regul

Palabras claves:

clinical trials, Latin American populations, metabolic genotypes, Metabolic phenotypes, native populations, pharmacogenetics, pharmacovigilance

Adrián LLerena, Altamirano C., Céspedes-Garro C., Enrique Terán, Francisco J.López Hernández, Galaviz-Hernandez C., Humberto Fariñas, Jung-Cook H., López-López M., MARTHA FORS, Martha M. Fors-López, Moya G.E., Ramirez R., Remírez D., Sosa-Macías M.G., Tarazona-Santos E.M., William F. Waters

Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital

Abstract: Aim: We evaluated the potential influence of genetic (CYP3A5, EPHX1, NR1I2, HNF4A, ABCC2, RALBP1, SC

Palabras claves:

ABCC2, carbamazepine, EPHX1, Epilepsy, NR1I2, pharmacogenetics

Adrián LLerena, Dorado P., Fricke-Galindo I., Jung-Cook H., López-López M., Martínez-Juárez I.E., Monroy-Jaramillo N., Ortega-Vázquez A., Penãs-Lledó E.M., Rojas-Tomé I.S.